Associated Papers
Multidimensional quantitative phenotypic and molecular analysis reveals neomorphic behaviors of p53 missense mutants.
Pal A et al.
Npj Breast Cancer, 2023
37773066 (PubMed )
Supplement: 41523_2023_582_MOESM1_ESM.pdf
Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe.
Asl ER et al.
Life Sciences, 2023
Dual NGS Comparative Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Samples of Non-Small Cell Lung Carcinoma (NSCLC).
Buburuzan L et al.
Cancers, 2022
Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition.
Semenov O et al.
Frontiers in Molecular Biosciences, 2022
Targeted Sequencing of Sorted Esophageal Adenocarcinoma Cells Unveils Known and Novel Mutations in the Separated Subpopulations.
Isidori F et al.
Clinical and Translational Gastroenterology, 2020
33094962 (PubMed )
Supplement: ct9-11-e00202-s004.docx
Diverse and cancer type‑specific roles of the p53 R248Q gain‑of‑function mutation in cancer migration and invasiveness.
Olszewski MB et al.
International Journal of Oncology, 2019
Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.
Iwanicki MP et al.
Jci Insight, 2016
Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.
Tepper CG et al.
The Prostate, 2005
Select a paper to view details